Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study
Year: 2012
Type: article
Study design: Clinical Trial
Source: Blood
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2093353574
